Trium Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Trium Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-78,451	Closed	-$1.56M	–	102
2023 Q1	$1.56M	Buy	+78,451	New	+$1.35M	0.54%	47

Other funds holding CSII

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Trium Capital's CSII Position: Q2 2023 in Review

Trium Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 78,451 shares — an estimated $1.56M sold.

Trium Capital first reported a position in CSII in Q1 2023 and held it in 1 quarter. The position peaked at $1.56M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Trium Capital reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Trium Capital sold 78,451 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $1.56M.
Trium Capital first reported a position in Cardiovascular Systems, Inc. in Q1 2023 and held it in 1 quarter.
Trium Capital's Cardiovascular Systems, Inc. position peaked at $1.56M in Q1 2023.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Trium Capital's 13F filing for Q2 2023, filed 11 Aug 2023.